Gefitinib in Combination With Anlotinib or Placebo in Previously Untreated EGFR-mutant NSCLC
Clinical trial NCT04028778 · UNKNOWN
Trial details
- NCT number
- NCT04028778
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-10
- Primary completion
- 2020-12-01
- Enrollment
- 310
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.